(Q34207596)

31 July 2017

1 reference

title

Viral vectors for dendritic cell-based immunotherapy. (English)

1 reference

31 July 2017

1 reference

1 reference

Jenne L

1

1 reference

31 July 2017

Schuler G

series ordinal

2

1 reference

31 July 2017

Steinkasserer A

series ordinal

3

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

22

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

102-107

1 reference

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Viral mechanisms of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Viral subversion of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Interactions of viruses with dendritic cells: a double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Poxviruses as expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Adenovirus vectors as recombinant viral vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Efficient expression of the tumor-associated antigen MAGE-3 in human dendritic cells, using an avian influenza virus vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Efficient retrovirus-mediated gene transfer of dendritic cells generated from CD34+ cord blood cells under serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

The role of B7 costimulation in T-cell immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901813-5

7 January 2021

10.1016/S1471-4906(00)01813-5

Identifiers

DOI

1 reference

31 July 2017

1 reference